Clinical trial
Mistral Percutaneous Tricuspid Valve Durable Repair Pivotal Study
NCT05767645 is registered in ClinicalTrials.gov with Mitralix as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mistral Percutaneous Tricuspid Valve Durable Repair Pivotal Study
- Lead sponsor
- Mitralix
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 21, 2021
- Completion date
- September 1, 2025
- Enrollment
- 75 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
tricuspid valve regurgitation